TrialClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2010

Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.

Gary R Lichtenstein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.